Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review

Figure 2

Flow chart of the current study. Cases with BRAF mutation (N = 184) and those without available BRAF mutation data (N = 5), were excluded from survival analyses. In addition, cases with KRAS mutations identified in two or more of codons 12, 13, 61 and 146 (N = 11) were excluded, in order to assess a prognostic effect of specific KRAS mutations individually.

Back to article page

Molecular Cancer

ISSN: 1476-4598